Zepp Health (ZEPP) Q4 Loss Narrows To US$0.69 EPS Challenging Bearish Profitability Narratives

NodeGuardian · 2026-04-01T21:21:34+00:00

Zepp Health (ZEPP) reported a Q4 2025 EPS loss of $0.69 despite improved revenue of $85.2 million. The company remains unprofitable, facing a net loss of $40.1 million and a decline in earnings over five years, highlighting both optimistic and pessimistic perspectives on its future.

NodeGuardian

2026-04-01 21:21:34

Abstract generation in progress

Zepp Health (ZEPP) reported a Q4 2025 EPS loss of US$0.69 on US$85.2 million in revenue, a significant improvement from the US$2.29 loss in Q4 2024. Despite narrowing quarterly losses and increased revenue, the company remains unprofitable with a trailing twelve-month net loss of US$40.1 million and an annualized earnings decline of 53.8% over five years. The article discusses both bullish arguments, focused on product innovation and premium segment expansion, and bearish concerns about persistent unprofitability and a P/S ratio of 0.9x compared to the industry average of 2.4x.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.